Nevertheless our study indicated the need to conduct a double-blind clinical trial to determine not only the preventive effect of ACE inhibitors on AD in the absence of ApoE4 but also a possible harmful effect of peripheral ACE inhibitors on the risk of AD in the presence of ApoE4. The gene discussed is ACE; the disease is Alzheimer disease.